Skip to content

Fear generalization: a direct replication of Lissek et al. (2010)

Fear generalization: a direct replication of Lissek et al. (2010) - Fear generalization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49639
Enrollment
120
Registered
2020-03-24
Start date
2021-09-03
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic Panic disorder

Interventions

This study uses a fear generalization procedure consisting of three phases: pre-acquisition, fear acquisition, and a generalization test. In the pre-acquisition phase participants will see a small a
GSs). Fear responses will be measured primarily by measuring startle responses, via electromyography (EMG), to a loud noise during the CS and GS presentations. Additionally, risk ratings as well as

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Comparison subjects have to be free of any current or past axis I psychopathology as assessed by the Structured Clinical Interview for DSM-IV-TR, Patient Edition (SCID; American Psychiatric Association, 2000). Participants in the experimental condition have to be free from current major depressive disorder, a current or past history of bipolar depression, psychosis and delusional disorders, and they must be diagnosed with a panic disorder. All participants should be between 18 and 65 years old and should be capable of making a reasoned review of their interest with regard to the research, i.e. giving informed consent.

Exclusion criteria

Exclusion criteria: A history of alcohol or substance abuse or dependence (other than nicotine) within 6 months before study start; current (possible) pregnancy; cardiovascular problems or disease; trouble seeing (unless corrected by glasses or contact lenses); trouble hearing (unless corrected by hearing aids); an electrical implant (such as a pacemaker, ICD or neurostimulator).

Design outcomes

Primary

MeasureTime frame
Electromyography (EMG) responses and reported risk ratings for each CS and GS. Online risk ratings and reaction time for the risk ratings. Both electromyograph responses and risk ratings will be used to test between-group differences in the course of learning.

Secondary

MeasureTime frame
A self-report of anxiety levels after the main experiment will be used for testing between group differences. The Panic Disorder Severity Scale (Shear et al. 1997), State-Trait Anxiety Inventory (Spielberger et al. 1983) and Beck Depression Inventory (Beck et al. 1996) will be used to test for between group differences before the beginning of the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)